Table 6.
Reference | Article type | Outcome | Study Period |
---|---|---|---|
Huang et al.21 | Mini-Review | Emphasis on the global COVID-19 vaccine development with available data. | May 2021 |
Buchy et al.22 | Review | Focused on the human experience in handling earlier pandemics and COVID-19 vaccine development measures. | April 2021 |
ElBagoury et al.23 | Full Review | Describes the preventive precautions taken to flatten the COVID-19 curve, as well as the challenges and potential for vaccine development. | August 2020 |
Calina et al.24 | Review | Effective COVID-19 vaccination should be regarded key public health goals to create an effective vaccine, as well as initiatives to deploy immune-enhancing strategic treatments and short-term activities. | April 2020 |
Kashte et al.25 | Review | Reviewed different types of vaccinations with examples of COVID-19 vaccines, their quick development compared to traditional vaccines. Also, established that, to avoid severe adverse outcomes, pre-clinical trials must be conducted with caution. | February 2021 |
Le et al.13 | News Analysis | This study found that vaccinations could be available under emergency use or comparable protocols by early 2021, based on worldwide vaccine R&D efforts and quick changes in the vaccine development process. | April 2020 |
Islam et al.19 | Research | A community-based cross-sectional study in Bangladesh that focused on the public’s perception of the COVID-19 immunization campaign. However, the study shows that the general population in Bangladesh has inadequate knowledge but positive sentiments regarding the COVID-19 vaccine. | March 2021 |